Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp

Bullboard Posts

Comment by AaronEggson Jun 22, 2020 4:18pm

253 Views

Post# 31178191

RE:RE:RE:Any insight on Q2 earnings?

Sure you can, extractors are trading between 1 and 2.5 x revenue, Valens being the 2.5. If they pull in 11 mil rev at valens rate you get a 114 mil mcap or an 0.85 share price. You think medipharm deserves a higher multiple?

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal